uniQure (QURE) Goodwill & Intangibles (2015 - 2026)
uniQure (QURE) posted quarterly Goodwill & Intangibles of $86.7 million for Q2 2026, down 14.12% year-over-year from $100.9 million in Q2 2025, and down 8.56% quarter-over-quarter from $94.8 million in Q1 2026.
Analysis
uniQure (QURE) Goodwill & Intangibles (2015 - 2026) Analysis & Trends
uniQure's Goodwill & Intangibles history runs 12 years deep, the most recent figure standing at $86.7 million for Q2 2026.
- In Q2 2026, Goodwill & Intangibles fell 14.12% year-over-year to $86.7 million; the TTM figure through Jun 2026 stood at $86.7 million (down 14.12% YoY), while the FY2025 annual figure was $98.1 million, up 1.15% from the prior year.
- Goodwill & Intangibles for Q2 2026 stood at $86.7 million, down from $94.8 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $100.9 million in Q2 2025, with the low at $77.3 million in Q3 2022.
- The 5-year median for Goodwill & Intangibles is $87.2 million (2022), against an average of $89.7 million.
- Peak annual rise in Goodwill & Intangibles reached 2506.77% in 2022, while the deepest fall reached 16.09% in 2022.
- uniQure's Goodwill & Intangibles stood at $84.4 million in 2022, then gained by 4.22% to $87.9 million in 2023, then gained by 10.36% to $97.0 million in 2024, then grew by 1.15% to $98.1 million in 2025, then fell by 11.67% to $86.7 million in 2026.
- Business Quant data shows QURE's Goodwill & Intangibles at $86.7 million in Q2 2026, $94.8 million in Q1 2026, and $98.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.69 Mn |
| Mar 31, 2026 | 94.80 Mn |
| Dec 31, 2025 | 98.15 Mn |
| Sep 30, 2025 | 99.47 Mn |
| Jun 30, 2025 | 100.94 Mn |
| Mar 31, 2025 | 95.34 Mn |
| Dec 31, 2024 | 97.03 Mn |
| Sep 30, 2024 | 100.69 Mn |
| Jun 30, 2024 | 81.77 Mn |
| Mar 31, 2024 | 84.91 Mn |
| Dec 31, 2023 | 87.92 Mn |
| Sep 30, 2023 | 83.25 Mn |
| Jun 30, 2023 | 85.73 Mn |
| Mar 31, 2023 | 85.70 Mn |
| Dec 31, 2022 | 84.36 Mn |
| Sep 30, 2022 | 77.26 Mn |
| Jun 30, 2022 | 82.43 Mn |
| Mar 31, 2022 | 87.70 Mn |
| Dec 31, 2021 | 90.32 Mn |
| Sep 30, 2021 | 92.07 Mn |